Back to full portfolio

IPO - NASDAQ:IVVD

Biotech developing antibody-based therapies for viral diseases.
WEBSITE
Founder(s)
Laura Walker, Tillman Gerngross
THEME(S)
No items found.
SECTOR(S)
Healthcare
Investment Stage
Growth
Company Status
IPO/Public
Invivyd

Perspectives

More about Invivyd

Perspectives

Tenaciously working to fight viral threats

July 17, 2023
Invivyd
Invivyd

Tenaciously working to fight viral threats